Zusammenfassung
Kardiovaskuläre Erkrankungen sind zwar bei werdenden Müttern selten (0,2–4 %), sie sind aber die häufigste Ursache mütterlicher Sterblichkeit in den westlichen Industrienationen. In Deutschland sind nahezu 30.000 Schwangere jährlich von den teilweise lebensbedrohlichen Komplikationen betroffen. Die arterielle Hypertonie als die häufigste kardiovaskuläre Erkrankung während der Schwangerschaft betrifft 10 % aller schwangeren Frauen und führt signifikant häufiger zu Totgeburten und neonataler Morbidität. Hypertensive Erkrankungen während der Schwangerschaft sind darüber hinaus mit einem Anteil von 15 % die häufigste Ursache für die mütterliche Sterblichkeit.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Bonow RO, Carabello BA, Chatterjee K et al. (2008) Focused update incorporated into the ACC/ AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 118: e523–e661.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206–1252
Cockburn J, Moar VA, Ounsted M, Redman CW (1982) Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1: 647–649
Coppage KH, Sibai BM (2005) Treatment of hypertensive complications in pregnancy. Curr Pharm Des 11: 749–757
De Swiet M (2000) Maternal blood pressure and birthweight. Lancet 355: 81–82
Elrad H, Gleicher KJ (1985) Physiologic changs in normal pregnancy. In: Gleicher N (ed) Principles of of medical therapy in pregnancy. New York: Plenum medical, p33 ff.
European Society of Gynecology (ESC), Task Force for the Management of Cardiovascular Diseases during Pregnancy (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J 32 (24): 3147–3197
European Society of Hypertension (ESH), European Society of Gynecology (ESC), Task Force for the Management of Arterial Hypertension (2007) 2007 Guidelines for the management of arterial hypertension. Eur Heart J 28: 1462–1536
Geva T, Mauer MB, Striker L, Kirshon B, Pivarnik JM (1997) Effects of physiologic load of pregnancy on left ventricular contractility and remodeling. Am Heart J 133: 53–9
Gruppo di Studio Ipertensione in Gravidanza (1998) Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. Br J Obstet Gynaecol 105: 718–722
Iffy L, McArdle JJ, Ganesh V, Hopp L (1996) Bromocriptine related atypical vascular accidents postpartum dentified through medicolegal reviews. Med Law 15: 127–134
Levine RJ, Ewell MG, Hauth JC, Curet LB, Catalano PM, Morris CD, Choudhary G, Sibai BM (2003) Should the definition of preeclampsia include a risein diastolic blood pressure of ≥15 mm Hg to a level ,90 mm Hg in association with proteinuria? Am J Obstet Gynecol 2000;183:787–792of High Blood Pressure. Hypertension 42: 1206–1252
Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P (2003) Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ 327: 955–960
Mancia G, De Backer G, Dominiczak A et al. (2007) ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 25: 1751–1762
Marcoux S. Berube S, Brisson J, Fabia J (1992) Histroy of migraine and risk of pregnancy-induced hypertension. Epidemiology 3: 53–56
Regitz-Zagrosek V, Gohlke-Bärwolf C, Geibel-Zehender A, Haass M, Kaemmerer H, Kruck I, Nienaber C (2008) Heart diseases in pregnancy. Clin Res Cardiol 97: 630–65
Shivvers SA, Wians FH Jr, Keffer JH, Ramin SM (1999) Maternal cardiac troponin I levels during normal labor and delivery. Am J Obstet Gynecol 180: 122
Sibai BM, Mabie WC, Shamsa F, Vilnar MA, Anderson GD (1990) A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 162: 960–967
von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA (2000) Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 355: 87–92
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bachelier, K., Böhm, M. (2014). Die Patientin mit Hypertonie. In: Gnoth, C., Mallmann, P. (eds) Perikonzeptionelle Frauenheilkunde. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-38023-5_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-38023-5_14
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-38022-8
Online ISBN: 978-3-642-38023-5
eBook Packages: Medicine (German Language)